180 related articles for article (PubMed ID: 2439997)
1. Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
Morady F; DiCarlo LA; Baerman JM; De Buitleir M
Pacing Clin Electrophysiol; 1987 May; 10(3 Pt 1):492-6. PubMed ID: 2439997
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravenous adenosine on antegrade refractoriness of accessory atrioventricular connections.
Garratt CJ; Griffith MJ; O'Nunain S; Ward DE; Camm AJ
Circulation; 1991 Nov; 84(5):1962-8. PubMed ID: 1934371
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome.
Milstein S; Klein GJ; Rattes MF; Sharma AD; Yee R
J Am Coll Cardiol; 1987 Dec; 10(6):1244-8. PubMed ID: 3680792
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation in Wolff-Parkinson-White syndrome: reversal of isoproterenol effects by sotalol.
Madrid AH; Moro C; Maŕin Huerta EM; Novo L; Mestre JL
Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2111-5. PubMed ID: 1279609
[TBL] [Abstract][Full Text] [Related]
5. Role of atrial fibrillation and atrioventricular conduction (including Wolff-Parkinson-White syndrome) in sudden death.
Meijler FL; van der Tweel I; Herbschleb JN; Hauer RN; Robles de Medina EO
J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):17B-22B. PubMed ID: 3998333
[TBL] [Abstract][Full Text] [Related]
6. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
Spurrell RA; Thorburn CW; Camm J; Sowton E; Deuchar DC
Br Heart J; 1975 Aug; 37(8):861-7. PubMed ID: 53057
[TBL] [Abstract][Full Text] [Related]
7. Magnesium reversal of digoxin-facilitated ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
Merrill JJ; DeWeese G; Wharton JM
Am J Med; 1994 Jul; 97(1):25-8. PubMed ID: 8030653
[TBL] [Abstract][Full Text] [Related]
8. Reversible protective effect of propafenone or flecainide during atrial fibrillation in patients with an accessory atrioventricular connection.
Auricchio A
Am Heart J; 1992 Oct; 124(4):932-7. PubMed ID: 1529904
[TBL] [Abstract][Full Text] [Related]
9. The electrophysiologic effects of intravenous propranolol in the Wolff-Parkinson-White syndrome.
Barrett PA; Jordan JL; Mandel WJ; Yamaguchi I; Laks MM
Am Heart J; 1979 Aug; 98(2):213-24. PubMed ID: 453024
[TBL] [Abstract][Full Text] [Related]
10. Pre-excited RR intervals during atrial fibrillation in the Wolff-Parkinson-White syndrome: influence of the atrioventricular node refractory period.
Fujimura O; Kuo CS; Smith BA
J Am Coll Cardiol; 1991 Dec; 18(7):1722-6. PubMed ID: 1960320
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of isoproterenol during atrial fibrillation in evaluation of asymptomatic Wolff-Parkinson-White pattern.
Szabo TS; Klein GJ; Sharma AD; Yee R; Milstein S
Am J Cardiol; 1989 Jan; 63(3):187-92. PubMed ID: 2909998
[TBL] [Abstract][Full Text] [Related]
12. Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome.
Swerdlow CD; Peterson J; Liem LB
Am J Cardiol; 1988 Jul; 62(1):78-82. PubMed ID: 2898208
[TBL] [Abstract][Full Text] [Related]
13. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia.
Sharpe MD; Dobkowski WB; Murkin JM; Klein G; Yee R
Anesthesiology; 1995 Apr; 82(4):888-95. PubMed ID: 7717560
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation in patients with an accessory pathway: importance of the conduction properties of the accessory pathway.
Della Bella P; Brugada P; Talajic M; Lemery R; Torner P; Lezaun R; Dugernier T; Wellens HJ
J Am Coll Cardiol; 1991 May; 17(6):1352-6. PubMed ID: 2016453
[TBL] [Abstract][Full Text] [Related]
16. Malignant ventricular arrhythmia in the Wolff-Parkinson-White syndrome during amiodarone treatment.
Perticone F; Cuda G; Spadea F; Pintaudi C; Tropea R
Clin Cardiol; 1987 Aug; 10(8):477-80. PubMed ID: 3621696
[TBL] [Abstract][Full Text] [Related]
17. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
[TBL] [Abstract][Full Text] [Related]
18. Wolff-Parkinson-White syndrome and atrial fibrillation. Relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation.
Wellens HJ; Durrer D
Am J Cardiol; 1974 Dec; 34(7):777-82. PubMed ID: 4432808
[No Abstract] [Full Text] [Related]
19. Efficacy of Nifekalant in Patients With Wolff-Parkinson-White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings.
Hu J; Yu J; Chen Q; Hu J; Huang Q; Xia Z; Xia Z; Ju Z; Yuan P; Fan S; Xiong Q; Zhu B; Huang L; You C; Bao H; Wu Y; Cheng X; Li J; Marian AJ; Hong K
J Am Heart Assoc; 2019 Jul; 8(13):e012511. PubMed ID: 31234695
[TBL] [Abstract][Full Text] [Related]
20. An "account" of digitalis and atrial fibrillation.
Meijler FL
J Am Coll Cardiol; 1985 May; 5(5 Suppl A):60A-68A. PubMed ID: 3886753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
